Form 4 Filing for Jimenez Freddy A. at Celldex Therapeutics, Inc.

This filing reports a stock option grant to Freddy A. Jimenez, SVP & General Counsel at Celldex Therapeutics, Inc. The grant includes 93,000 Incentive Stock Options with a purchase price of $0.00, for the underlying security of Common Stock. The options have an exercise date of June 25, 2027, and an expiration date of June 25, 2036. Vesting begins with 25% on June 25, 2027, followed by quarterly vesting over the subsequent 12 quarters. The transaction date was June 25, 2026, and the filing was signed on June 29, 2026, by Sam Martin as attorney-in-fact for Mr. Jimenez. This option was granted under the company's 2021 Omnibus Equity Incentive Plan.